Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Martinelli

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 18, 2021
Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessmentAntonino Ditto, Loris De Cecco, Biagio Paolini, et al.
Journal of Minimally Invasive Gynecology|May 9, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective ExperienceGiorgio Bogani, Elena Tagliabue, Mauro Signorelli, et al.
Nutrients|July 9, 2022
Vitamin D Status, Cardiovascular Risk Profile, and miRNA-21 Levels in Hypertensive Patients: Results of the HYPODD StudyDomenico Rendina, Lanfranco D Elia, Veronica Abate, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2018
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional StudyFrancesco Raspagliesi, Giorgio Bogani, Laura Matteucci, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 27, 2016
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancerGiorgio Bogani, Ilaria Sabatucci, Giuseppa Maltese, et al.
Gynecologic Oncology|August 7, 2017
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analysesGiorgio Bogani, Elena Tagliabue, Antonino Ditto, et al.
Journal of Minimally Invasive Gynecology|February 23, 2017
Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysisGiorgio Bogani, Chiara Borghi, Umberto Leone Roberti Maggiore, et al.
Journal of Minimally Invasive Gynecology|March 29, 2017
Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer StagingGiorgio Bogani, Chiara Borghi, Antonino Ditto, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 9, 2017
The association of pre-treatment HPV subtypes with recurrence of VINGiorgio Bogani, Fabio Martinelli, Antonino Ditto, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 2017
Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasiaGiorgio Bogani, Fabio Martinelli, Antonino Ditto, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|December 18, 2021
Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessmentAntonino Ditto, Loris De Cecco, Biagio Paolini, et al.
Journal of Minimally Invasive Gynecology|May 9, 2017
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective ExperienceGiorgio Bogani, Elena Tagliabue, Mauro Signorelli, et al.
Nutrients|July 9, 2022
Vitamin D Status, Cardiovascular Risk Profile, and miRNA-21 Levels in Hypertensive Patients: Results of the HYPODD StudyDomenico Rendina, Lanfranco D Elia, Veronica Abate, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2018
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional StudyFrancesco Raspagliesi, Giorgio Bogani, Laura Matteucci, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 27, 2016
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancerGiorgio Bogani, Ilaria Sabatucci, Giuseppa Maltese, et al.
Gynecologic Oncology|August 7, 2017
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analysesGiorgio Bogani, Elena Tagliabue, Antonino Ditto, et al.
Journal of Minimally Invasive Gynecology|February 23, 2017
Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysisGiorgio Bogani, Chiara Borghi, Umberto Leone Roberti Maggiore, et al.
Journal of Minimally Invasive Gynecology|March 29, 2017
Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer StagingGiorgio Bogani, Chiara Borghi, Antonino Ditto, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 9, 2017
The association of pre-treatment HPV subtypes with recurrence of VINGiorgio Bogani, Fabio Martinelli, Antonino Ditto, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 2017
Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasiaGiorgio Bogani, Fabio Martinelli, Antonino Ditto, et al.
Pageof 15